Doximity Board Shake-up: Director Departs, New Director Appointed

Ticker: DOCS · Form: 8-K · Filed: Aug 15, 2025 · CIK: 1516513

Doximity, Inc. 8-K Filing Summary
FieldDetail
CompanyDoximity, Inc. (DOCS)
Form Type8-K
Filed DateAug 15, 2025
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: board-changes, director-resignation, director-appointment

Related Tickers: DOCS

TL;DR

Doximity's board sees a change: Dr. Gold out, Dr. Abernethy in.

AI Summary

Doximity, Inc. announced on August 13, 2025, changes in its executive and director roles. Specifically, Dr. Jeffrey A. Gold, a Class III Director, resigned from the Board of Directors. Concurrently, the company appointed Dr. Amy Abernethy as a new Class III Director and also as a member of the Nominating and Governance Committee.

Why It Matters

Changes in board composition can signal shifts in company strategy or governance, potentially impacting investor confidence and future decision-making.

Risk Assessment

Risk Level: low — The filing reports routine changes in board membership, which typically carry low immediate risk.

Key Players & Entities

  • Doximity, Inc. (company) — Registrant
  • Dr. Jeffrey A. Gold (person) — Resigning Class III Director
  • Dr. Amy Abernethy (person) — Appointed Class III Director and Nominating and Governance Committee member
  • August 13, 2025 (date) — Date of earliest event reported

FAQ

Who resigned from Doximity's Board of Directors?

Dr. Jeffrey A. Gold resigned from the Board of Directors.

When was the earliest event reported in this filing?

The earliest event reported was on August 13, 2025.

Who was appointed as a new Class III Director at Doximity?

Dr. Amy Abernethy was appointed as a new Class III Director.

What committee was Dr. Amy Abernethy appointed to?

Dr. Amy Abernethy was appointed to the Nominating and Governance Committee.

What is Doximity, Inc.'s state of incorporation?

Doximity, Inc. is incorporated in Delaware.

Filing Stats: 453 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2025-08-15 16:01:54

Key Financial Figures

  • $0.001 — which registered Class A common stock, $0.001 par value per share DOCS The New York S

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 15, 2025 DOXIMITY, INC. By: /s/ Anna Bryson Anna Bryson Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.